In the Fudan cohort, aberrant glycolysis and alterations in its key enzyme, PGK1, which was negatively correlated with overall survival rate, were noticed at the multi-omics level, and promoted ESCC cell proliferation and tumor growth. This evidence concerns the gene PGK1 and esophageal squamous cell carcinoma.